Publications by authors named "Steven Faulkner"

Background: Atopic dermatitis is a chronic inflammatory skin disease that affects up to 13% of children and 10% of adults in the United States. Among patients and their families, atopic dermatitis has a considerable effect on quality of life and represents a substantial economic burden.

Objective: To describe the impact and challenges of atopic dermatitis and to provide nondermatologists in the healthcare community an enhanced understanding of atopic dermatitis to facilitate treatment and pharmacy benefit discussions.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a common skin condition treated with topical corticosteroids (TCS) and calcineurin inhibitors (TCI), and crisaborole is a newly approved non-steroidal treatment for mild-to-moderate cases.
  • The study assesses the real-world use and costs of TCS and TCI, as well as the budget impact of introducing crisaborole over two years for health insurance providers.
  • Results showed that while the budget impact of crisaborole was relatively modest—a cost increase of $350,946 for TCS/TCI patients—its adoption could lower costs for patients using TCIs by about $22,871.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines factors affecting healthcare resource utilization in patients with fibromyalgia (FM), utilizing a large electronic health records database to analyze de-identified data from 2008 to 2012.
  • Results reveal that patients are mostly middle-aged women, with high healthcare usage primarily related to medication orders and physician visits, with opioids being the most frequently prescribed medication.
  • Significant drivers of healthcare resource use include racial differences, with African-Americans showing higher utilization, and the presence of comorbid conditions like musculoskeletal pain and congestive heart failure, highlighting the complexity of managing fibromyalgia.
View Article and Find Full Text PDF
Article Synopsis
  • * Measurements taken included pain severity, health profile, analgesic use, and spinal flexion, showing significant improvements in pain and health indicators for both acupuncture and TENS groups, lasting even 3 months post-treatment.
  • * Acupuncture was found to provide a small yet significant improvement in spinal flexion that did not persist at follow-up, and the effectiveness of both treatments could potentially be influenced by a placebo effect.
View Article and Find Full Text PDF